Trials / Completed
CompletedNCT00846482
Exploratory Study Of The ERCC-1 Gene
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is for patients with advanced or stage II and III colon or rectal cancer. The primary purpose of this research study is to determine if a particular protein in the patient's blood will change when they receive treatment with a drug called oxaliplatin, which is used to treat the colon or rectal cancer. This protein is called ERCC-1. It is thought that the amount of this protein in the blood could influence the manner in which the patient responds to oxaliplatin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin | Oxaliplatin will be administered once every 2 or 3 weeks |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2009-02-18
- Last updated
- 2020-09-16
- Results posted
- 2020-09-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00846482. Inclusion in this directory is not an endorsement.